Merck announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review a supplemental Biologics License Application (sBLA) for VAXNEUVANCE (Pneumococcal 15-valent Conjugate Vaccine) for the prevention of invasive pneumococcal...
Researchers at CDDEP, Berkeley, and Imperial College London assessed the impact of PCVs and rotavirus vaccines on antibiotic consumption among children in low- and middle-income countries.